Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 13;9(1):7295.
doi: 10.1038/s41598-019-43870-8.

The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model

Affiliations

The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model

Ali Kermanizadeh et al. Sci Rep. .

Abstract

The potential for nanomaterial (NM) translocation to secondary organs is a realistic prospect, with the liver one of the most important target organs. Traditional in vitro or ex vivo hepatic toxicology models are often limiting and/or troublesome (i.e. short life-span reduced metabolic activity, lacking important cell populations, high inter-individual variability, etc.). Building on previous work, this study utilises a 3D human liver microtissue (MT) model (MT composed of mono-culture of hepatocytes or two different co-culture MT systems with non-parenchymal cell (NPC) fraction sourced from different donors) to investigate the importance of inter-donor variability of the non-parenchymal cell population in the overall governance of toxicological response following exposure to a panel of NMs. To the best of our knowledge, this is the first study of its kind to investigate inter-donor variability in hepatic NPC population. The data showed that the Kupffer cells were crucial in dictating the overall hepatic toxicity following exposure to the materials. Furthermore, a statistically significant difference was noted between the two co-culture MT models. However, the trend for particle-induced biological responses was similar between the co-cultures (cytotoxicity, cytokine production and caspase activity). Therefore, despite the recognition of some discrepancies in the absolute values between the co-culture models, the fact that the trends and patterns of biological responses were comparable between the multi-cellular models we propose the 3D liver MT to be a valuable tool in particle toxicology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Cytotoxicity in human liver MT (mono-culture of hepatocytes only, co-culture of hepatocytes with NPC fraction from donor 1 and co-culture of hepatocytes with NPC from donor 2) following single or repeated exposures to a panel of engineered NMs for up 120 hr. The cytotoxicity as measured by AK release via ToxiLight™ cytotoxicity assay (a) 24 hr (b) 72 hr and (c) 120 hr (NM treatments µg/ml). Triton-X was utilised as a positive control in the cytotoxicity assay (24 hr exposure). The values represent mean ± SEM (n = 3) with significance indicated by *p < 0.05 and **p < 0.005 of NM-induced effects compared to negative control, #p < 0.05 and ##p < 0.005 signifying differences between the mono-culture and the co-culture and $p < 0.05 and $$p < 0.005 highlighting variation between co-culture 1 and co-culture 2.
Figure 2
Figure 2
IL8, IL6 secretion from NM exposed human liver MT. The tissues were exposed to cell medium (cont) or NMs for a period of 24 hr (a) IL8 (b) IL6. The values represent mean ± SEM (n = 3) with significance indicated by *p < 0.05 and **p < 0.005 of NM-induced effects compared to negative control, #p < 0.05 and ##p < 0.005 signifying statistical differences between the mono-culture and the co-culture and $p < 0.05 and $$p < 0.005 highlighting variation between co-culture 1 and co-culture 2.
Figure 3
Figure 3
IL8, IL6 and IL10 secretion from NM exposed human liver MT. The tissues were exposed to cell medium (cont) or NMs for a period of 72 hr (a) IL8 (b) IL6 and (c) IL10. The values represent mean ± SEM (n = 3) with significance indicated by *p < 0.05 and **p < 0.005 of NM-induced effects compared to negative control, #p < 0.05 and ##p < 0.005 signifying statistical differences between the mono-culture and the co-culture and $p < 0.05 and $$p < 0.005 highlighting variation between co-culture 1 and co-culture 2.
Figure 4
Figure 4
IL8, IL6 and IL10 secretion from NM exposed human liver MT. The tissues were exposed to cell medium (cont) or NMs for a period of 120 hr (a) IL8 (b) IL6 and (c) IL10. The values represent mean ± SEM (n = 3) with significance indicated by *p < 0.05 and **p < 0.005 of NM-induced effects compared to negative control, #p < 0.05 and ##p < 0.005 signifying statistical differences between the mono-culture and the co-culture and $p < 0.05 and $$p < 0.005 highlighting variation between co-culture 1 and co-culture 2.
Figure 5
Figure 5
Caspase activity in 3D human liver MT. The effect of NM exposure (or positive control Camptothecin (Campto)) on caspase 3/7 activity in the human liver MT (a) 24 hr (b) 120 hr. The values represent mean ± SEM (n = 3) with significance indicated by *p < 0.05 and **p < 0.005 of NM-induced effects compared to negative control, #p < 0.05 and ##p < 0.005 signifying statistical differences between the mono-culture and the co-culture and $p < 0.05 and $$p < 0.005 highlighting variation between co-culture 1 and co-culture 2.

References

    1. Kermanizadeh A, Powell L, Stone V, Møller P. Nano delivery systems and stabilized solid drug nanoparticles for orally administered medicine - current landscape. International Journal of Nanomedicine. 2018;13:7575–7605. doi: 10.2147/IJN.S177418. - DOI - PMC - PubMed
    1. Vance ME, et al. Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory. Beilstein Journal of Nanotechnology. 2015;6:1769–1780. doi: 10.3762/bjnano.6.181. - DOI - PMC - PubMed
    1. Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials with therapeutic and diagnosis applications. Journal of Controlled Release. 2012;164:307–313. doi: 10.1016/j.jconrel.2012.08.018. - DOI - PubMed
    1. Kermanizadeh A, Balharry D, Wallin H, Loft S, Møller P. Nanomaterial translocation - the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs - a review. Critical Reviews of Toxicology. 2015;45:837–872. doi: 10.3109/10408444.2015.1058747. - DOI - PubMed
    1. Tetley TD. Health effects of nanomaterials. Biochemical Society Transactions. 2007;35:527–531. doi: 10.1042/BST0350527. - DOI - PubMed

Publication types